Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/28/2025 | Mkt Perform | Raymond James | |
| 7/17/2024 | $344.00 → $392.00 | Buy | Lake Street |
| 3/20/2024 | Market Outperform | CJS Securities | |
| 2/6/2024 | Sector Weight | KeyBanc Capital Markets | |
| 12/21/2022 | $124.00 | Buy | Lake Street |
| 6/22/2022 | $110.00 | Buy | Lake Street |
| 11/19/2021 | $81.00 | Buy | Colliers Securities |
NEWBURYPORT, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets Healthcare Forum to be held virtually on March 18, 2025. UFP's presentation is scheduled to begin at 10:30 AM ET. About UFP Technologies, Inc.UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engine
NEWBURYPORT, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported 2024 net income of $59.0 million, 31.3% higher than net income of $44.9 million for 2023. Adjusted net income grew 32.5% to $67.6 million. Net sales for 2024 were $504.4 million, 26.1% higher than 2023 sales of $400.1 million. GAAP and adjusted earnings per diluted common share outstanding (EPS) were $7.58 and $8.68 respectively. For its fourth quarter ended December 31, 2024, the Company reported net income of $16.4 million, 41.1% higher than net income of $11.6 million in the same period of
NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th. About UFP Technologies, Inc. UFP Technologies is an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to man
Raymond James initiated coverage of UFP Technologies with a rating of Mkt Perform
Lake Street reiterated coverage of UFP Technologies with a rating of Buy and set a new price target of $392.00 from $344.00 previously
CJS Securities initiated coverage of UFP Technologies with a rating of Market Outperform
8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
10-K - UFP TECHNOLOGIES INC (0000914156) (Filer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)
SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)
NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th. About UFP Technologies, Inc. UFP Technologies is an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to man
NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Welch Fluorocarbon Inc. Founded in 1985 and headquartered in Dover, New Hampshire, Welch Fluorocarbon develops and manufactures thermoformed, and heat sealed implantable medical device components utilizing thin, high-performance films. "Welch Fluorocarbon will bring significant thin film thermoforming capabilities to our expanding MedTech portfolio of technologies and materials," said R. Jeffrey Bailly, chairman and C
NEWBURYPORT, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AJR Enterprises, LLC. Headquartered in St. Charles, Illinois, with additional manufacturing in the Dominican Republic, AJR Enterprises develops and manufactures single use safe patient handling systems. "We are very excited to add AJR Enterprises' capabilities to our patient surfaces portfolio," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Patient surfaces and transfer devices are a growing market due
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)
NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.
NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi
DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company's Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Company's 2024 Annual Meeting of Stockholders in June, after ten years of service. "We are pleased to welcome Marc to the Board of Directors. Marc's strategic insights and leadership will undoubtedly contribute to the continued growth and success of Chimerix as we wo